Valgraine en es it fr

Valgraine Brand names, Valgraine Analogs

Valgraine Brand Names Mixture

  • No information avaliable

Valgraine Chemical_Formula


Valgraine RX_link

Valgraine fda sheet

Valgraine FDA

Valgraine msds (material safety sheet)

Valgraine Synthesis Reference

No information avaliable

Valgraine Molecular Weight

387.711 g/mol

Valgraine Melting Point

No information avaliable

Valgraine H2O Solubility

No information avaliable

Valgraine State


Valgraine LogP


Valgraine Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Valgraine Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Valgraine Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Valgraine Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Valgraine side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Valgraine Patient Information

Valgraine Organisms Affected

Yeast and other fungi